KR100822532B1 - 알플러스알파-리포산의 합성 방법 - Google Patents
알플러스알파-리포산의 합성 방법 Download PDFInfo
- Publication number
- KR100822532B1 KR100822532B1 KR1020037004734A KR20037004734A KR100822532B1 KR 100822532 B1 KR100822532 B1 KR 100822532B1 KR 1020037004734 A KR1020037004734 A KR 1020037004734A KR 20037004734 A KR20037004734 A KR 20037004734A KR 100822532 B1 KR100822532 B1 KR 100822532B1
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- halo
- octanoic acid
- racemic
- halooctanoic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960002663 thioctic acid Drugs 0.000 title abstract description 13
- 238000001308 synthesis method Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 49
- 150000003839 salts Chemical class 0.000 claims abstract description 34
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims abstract description 30
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims abstract description 30
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000002253 acid Substances 0.000 claims abstract description 22
- 125000005907 alkyl ester group Chemical group 0.000 claims abstract description 22
- 239000003513 alkali Substances 0.000 claims abstract description 12
- 239000003960 organic solvent Substances 0.000 claims abstract description 12
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 9
- 150000002148 esters Chemical class 0.000 claims abstract description 8
- 238000003408 phase transfer catalysis Methods 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 150000007522 mineralic acids Chemical class 0.000 claims abstract description 6
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- 238000001953 recrystallisation Methods 0.000 claims abstract description 5
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- 238000000926 separation method Methods 0.000 claims description 10
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 9
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 7
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 claims description 6
- 125000001931 aliphatic group Chemical group 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- HSKAEXWPLIDFGC-UHFFFAOYSA-N 6,8-dichlorooctanoic acid Chemical compound OC(=O)CCCCC(Cl)CCCl HSKAEXWPLIDFGC-UHFFFAOYSA-N 0.000 claims description 5
- -1 aromatic carboxylic acids Chemical class 0.000 claims description 5
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical group 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 150000004702 methyl esters Chemical class 0.000 claims description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 4
- 150000004714 phosphonium salts Chemical class 0.000 claims description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 4
- SRRKNRDXURUMPP-UHFFFAOYSA-N sodium disulfide Chemical group [Na+].[Na+].[S-][S-] SRRKNRDXURUMPP-UHFFFAOYSA-N 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- LTJSXGVQCAVSJW-UHFFFAOYSA-N [K+].[K+].[S-][S-] Chemical compound [K+].[K+].[S-][S-] LTJSXGVQCAVSJW-UHFFFAOYSA-N 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 150000004292 cyclic ethers Chemical class 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 125000004494 ethyl ester group Chemical group 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 claims description 2
- 125000002560 nitrile group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- RKHXQBLJXBGEKF-UHFFFAOYSA-M tetrabutylphosphanium;bromide Chemical compound [Br-].CCCC[P+](CCCC)(CCCC)CCCC RKHXQBLJXBGEKF-UHFFFAOYSA-M 0.000 claims description 2
- 235000019136 lipoic acid Nutrition 0.000 abstract description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 7
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- VROFMCACQMRGHY-UHFFFAOYSA-N methyl 6,8-dichlorooctanoate Chemical compound COC(=O)CCCCC(Cl)CCCl VROFMCACQMRGHY-UHFFFAOYSA-N 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 description 1
- RQEUFEKYXDPUSK-ZETCQYMHSA-N (1S)-1-phenylethanamine Chemical compound C[C@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-ZETCQYMHSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical class OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Biological Depolymerization Polymers (AREA)
- General Preparation And Processing Of Foods (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
Abstract
Description
Claims (31)
- a) 라세미 6,8-할로옥탄산을 S(-)α-메틸벤질아민으로 염화시키는 단계(여기에서 S(-)α-메틸벤질아민/라세미 6,8-디-할로옥탄산의 몰비는 0.45 내지 0.65이다);b) R(+)6,8-디할로-옥탄산-S(-)α-메틸벤질아민의 결정화된 부분 입체 이성체성 염을 여과에 의해 분리시키는 단계;c) R(+)6,8-디할로-옥탄산-S(-)α-메틸벤질아민의 부분 입체 이성체성 염을 재결정에 의해 정제시키는 단계;d) 상기 부분 입체 이성체성 염을 2 내지 10 중량%로 희석된 수용액 중의 강한 무기산과 반응시킴으로써 분리시켜 R(+)6,8-디-할로옥탄산을 수득하는 단계;e) R(+)6,8-디-할로-옥탄산을 에스테르화시켜 상응하는 알킬 에스테르를 수득하는 단계;f) 하기 화학식을 갖는 4급 암모늄 또는 포스포늄 염들로 이루어진 그룹 중에서 선택된 상 전이 촉매 작용을 위한 화합물의 존재 하에서 유기 용매 중의 R(+)6,8-디-할로-옥탄산의 알킬 에스테르와 알칼리 디설파이드의 수용액을 반응시키는 단계:[상기 식에서,A는 질소 또는 인이고,X는 Cl, Br, I, HSO4 및 H2PO4로 이루어진 그룹 중에서 선택되고,치환체 R1, R2, R3 및 R4는 탄소수 1 내지 20(C1-C20)의 선형 및 분지된 알킬 라디칼로 이루어진 그룹 중에서 선택되고, 이때 상기 치환체들은 서로 동일하거나 또는 상이하거나, 또는 상기 치환체들 중 단지 하나만이 화학식 -(CH2)nC6H5(이때 n은 1 내지 16이다)의 아릴알킬 라디칼로 이루어진 그룹 중에서 선택된다];g) R(+)α-리포산의 에스테르를 가수분해시키는 단계를 포함하는 R(+)α-리포산의 합성 방법.
- 제 1 항에 있어서,서로 동일하거나 또는 상이한 라세미 6,8-디-할로-옥탄산의 할로겐 치환체들이 Cl, Br 및 I로 이루어진 그룹 중에서 선택되는 방법.
- 제 2 항에 있어서,라세미 6,8-디-할로-옥탄산이 6,8-디클로로옥탄산인 방법.
- 제 1 항에 있어서,염화 단계 a)에서 S(-)α-메틸벤질아민/라세미 6,8-디-할로옥탄산의 몰비가 0.48 내지 0.60인 방법.
- 제 4 항에 있어서,S(-)α-메틸벤질아민/라세미 6,8-디-할로옥탄산의 몰비가 0.50 내지 0.58인 방법.
- 제 1 항에 있어서,염화 단계 a)에서 라세미 6,8-디-할로옥탄산의 농도가 용매의 10 내지 40% w/v인 방법.
- 제 6 항에 있어서,라세미 6,8-디-할로옥탄산의 농도가 용매의 15 내지 35% w/v인 방법.
- 제 7 항에 있어서,라세미 6,8-디-할로옥탄산의 농도가 용매의 20 내지 30% w/v인 방법.
- 제 1 항에 있어서,단계 d), 즉 부분 입체 이성체성 염의 분리에서, 수성 무기산이 4 내지 8 중량%로 희석된 황산인 방법.
- 제 9 항에 있어서,황산이 5 중량%로 희석된 방법.
- 제 1 항에 있어서,R(+)6,8-디-할로-옥탄산의 알킬 에스테르가 선형이거나 또는 분지된 C1-C6 에스테르인 방법.
- 제 11 항에 있어서,R(+)6,8-디-할로옥탄산의 알킬 에스테르가 선형이거나 또는 분지된 C1-C3 에스테르인 방법.
- 제 12 항에 있어서,R(+)6,8-디-할로옥탄산의 알킬 에스테르가 메틸 에스테르 또는 에틸 에스테르인 방법.
- 제 1 항에 있어서,단계 f)에서 수행되는 반응에서 R(+)6,8-디-할로-옥탄산의 알킬 에스테르의 양이 유기 용매에 대해서 5 내지 60 중량%인 방법.
- 제 14 항에 있어서,R(+)6,8-디-할로-옥탄산의 알킬 에스테르의 양이 유기 용매에 대해서 10 내지 40 중량%인 방법.
- 제 15 항에 있어서,R(+)6,8-디-할로-옥탄산의 알킬 에스테르의 양이 유기 용매에 대해서 15 내지 30 중량%인 방법.
- 제 1 항에 있어서,단계 f)에서 수행되는 반응에서 사용되는 유기 용매가 물과 혼합될 수 없는 용매로, 선형 또는 분지된 지방족 C5-C10 탄화수소 또는 방향족 C5-C 10 탄화수소(또한 할로겐, 니트로 및 니트릴 그룹으로 이루어진 그룹 중에서 선택된 치환 그룹을 갖는다); 지방족 또는 방향족 카르복실산의 에스테르; 선형 또는 환상 에테르; 선형 또는 환상 C4-C10 케톤; 이황화 탄소; 사염화 탄소로 이루어진 그룹 중에서 선택되는 방법.
- 제 17 항에 있어서,용매가 벤젠 또는 톨루엔인 방법.
- 제 1 항에 있어서,알칼리 디설파이드가 이황화 나트륨(Na2S2) 또는 이황화 칼륨(K2S 2), 또는 이들의 혼합물인 방법.
- 제 19 항에 있어서,알칼리 디설파이드가 이황화 나트륨인 방법.
- 제 1 항에 있어서,단계 f)에서 수행되는 반응에서, 알칼리 디설파이드/R(+)6,8-디-할로-옥탄산의 알킬 에스테르의 몰비가 0.8 내지 1.2인 방법.
- 제 21 항에 있어서,몰비가 0.9 내지 1.1인 방법.
- 제 22 항에 있어서,몰비가 0.95 내지 1.0인 방법.
- 제 1 항에 있어서,4 급 암모늄 또는 포스포늄 염이 테트라부틸암모늄 브로마이드, 테트라부틸포스포늄 브로마이드, 메틸트리옥틸암모늄 클로라이드(ALIQUAT(등록상표) 336), 메틸-(C8-C10)-트리알킬암모늄 클로라이드(ADOGEN(등록상표) 464) 및 테트라부틸암모늄 하이드로겐설페이트로 이루어진 그룹 중에서 선택되는 방법.
- 제 24 항에 있어서,4 급 염이 테트라부틸암모늄 브로마이드 또는 테트라부틸암모늄 하이드로겐설페이트인 방법.
- 제 1 항에 있어서,4 급 암모늄 또는 포스포늄 염이 6,8-디-할로-옥탄산의 알킬 에스테르에 대해 0.5 내지 10 몰%의 양으로 존재하는 방법.
- 제 26 항에 있어서,4 급 염이 6,8-디-할로-옥탄산의 알킬 에스테르에 대해 1 내지 5 몰%의 양으로 존재하는 방법.
- 제 27 항에 있어서,4 급 염이 6,8-디-할로-옥탄산의 알킬 에스테르에 대해 2 내지 4 몰%의 양으로 존재하는 방법.
- 제 1 항에 있어서,단계 f)에서 수행되는 반응의 온도가 20 내지 130 ℃인 방법.
- 제 29 항에 있어서,온도가 60 내지 100 ℃인 방법.
- 제 30 항에 있어서,온도가 80 내지 90 ℃인 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2000A002188 | 2000-10-10 | ||
IT2000MI002188A IT1319196B1 (it) | 2000-10-10 | 2000-10-10 | Sintesi dell'acido r(+)alfa-lipoico. |
PCT/EP2001/011576 WO2002030919A1 (en) | 2000-10-10 | 2001-10-08 | SYNTHESIS OF R(+)α-LIPOIC ACID |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030070001A KR20030070001A (ko) | 2003-08-27 |
KR100822532B1 true KR100822532B1 (ko) | 2008-04-16 |
Family
ID=11445937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037004734A Expired - Fee Related KR100822532B1 (ko) | 2000-10-10 | 2001-10-08 | 알플러스알파-리포산의 합성 방법 |
Country Status (11)
Country | Link |
---|---|
US (1) | US6864374B2 (ko) |
EP (1) | EP1335911B1 (ko) |
JP (1) | JP4257574B2 (ko) |
KR (1) | KR100822532B1 (ko) |
AT (1) | ATE266020T1 (ko) |
AU (1) | AU2002220596A1 (ko) |
CZ (1) | CZ301710B6 (ko) |
DE (1) | DE60103179T2 (ko) |
ES (1) | ES2219577T3 (ko) |
IT (1) | IT1319196B1 (ko) |
WO (1) | WO2002030919A1 (ko) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10201464B4 (de) * | 2002-01-16 | 2005-06-16 | Viatris Gmbh & Co. Kg | Verfahren zur Herstellung reiner Thioctsäure |
ITMI20030831A1 (it) | 2003-04-22 | 2004-10-23 | Laboratorio Chimico Int Spa | Sale basico dell'acido tiottico con la l-carnitina. |
CN100387593C (zh) * | 2006-01-26 | 2008-05-14 | 南京师范大学 | 连续逆流液液萃取分离二硫辛酸与乙醇及碱水溶液的方法 |
ITMI20061024A1 (it) | 2006-05-25 | 2007-11-26 | Eurand Pharmaceuticals Ltd | Pellet a base di acido lipoico |
WO2010047717A1 (en) * | 2008-10-24 | 2010-04-29 | Biolink Life Sciences, Inc. | Stable, water-insoluble r-(+)-alpha-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities |
JP2012510511A (ja) * | 2008-12-01 | 2012-05-10 | インヴアスク セラピューテイックス インコーポレイテッド | レニン−アンジオテンシン−アルドステロン系阻害剤及びリポ酸化合物を含有する組成物、並びに、レニン−アンジオテンシン−アルドステロン系に関連した疾患の治療のためのそれらの使用 |
CN101880224B (zh) * | 2009-05-08 | 2013-02-20 | 上海医药工业研究院 | 一种6,8-二氯辛酸的拆分方法 |
US8080674B2 (en) * | 2009-06-12 | 2011-12-20 | Ampac Fine Chemicals Llc. | Preparation of polymer-free R-(+)-α-lipoic acid magnesium salt |
DE102012109704A1 (de) * | 2012-10-11 | 2014-04-17 | Epcos Ag | Keramisches Bauelement mit Schutzschicht und Verfahren zu dessen Herstellung |
CN109942426B (zh) * | 2019-04-02 | 2022-03-22 | 福建科宏生物工程股份有限公司 | 一种s-(-)-硫辛酸循环利用的处理方法 |
CN116496245B (zh) * | 2023-03-01 | 2024-10-01 | 杭州新曦科技有限公司 | 用于制备R-α-硫辛酸及其相关中间体的方法 |
CN116925035A (zh) * | 2023-07-27 | 2023-10-24 | 风火轮(上海)生物科技有限公司 | 一种硫辛酸的纯化方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5281722A (en) * | 1991-11-16 | 1994-01-25 | Degussa Ag | Preparation and use of salts of the pure enantiomers of alpha-lipoic acid |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3629116A1 (de) * | 1986-08-27 | 1988-03-10 | Asta Pharma Ag | Verfahren zur herstellung enantiomerenreiner r-(+)-(alpha)-liponsaeure und s-(-)-(alpha)-liponsaeure (thioctsaeure) sowie nonen- beziehungsweise mesylderivate als zwischenprodukte hierfuer |
DE3814163A1 (de) * | 1988-04-27 | 1989-11-09 | Rhein Chemie Rheinau Gmbh | Verfahren zur herstellung von disulfiden |
DE4342619A1 (de) * | 1993-12-14 | 1995-06-22 | Bayer Ag | Verbessertes Verfahren zur Herstellung von 2,2'-Dinitrodiphenyldisulfid |
DE19510130C1 (de) * | 1995-03-21 | 1996-11-21 | Asta Medica Ag | Verfahren zur Herstellung rieselfähiger R,S-Thioctsäure, R,S-Thioctsäure sowie deren Verwendung |
GB9510858D0 (en) * | 1995-05-30 | 1995-07-26 | Chiroscience Ltd | Process for preparing lipoic acid |
DE19533881A1 (de) * | 1995-09-13 | 1997-03-20 | Dresden Arzneimittel | Herstellung und Verwendung der reinen Enantiomere der 8-Chlor-6-sulfonyloxy-octansäuren und ihrer Alkylester und der reinen Enantiomere der 6,8-Dichlor-octansäure und ihrer Alkylester |
IL123887A0 (en) * | 1997-04-02 | 1998-10-30 | Sankyo Co | Dithiolan derivatives their use and pharmaceutical compositions containing the same |
ES2340488T3 (es) * | 1998-10-26 | 2010-06-04 | The Research Foundation Of State University Of New York | Sales derivadas del acido lipoico y su utilizacion para el tratamiento de las enfermedades. |
AR042572A1 (es) * | 1999-04-02 | 2005-06-29 | Sod Conseils Rech Applic | Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos |
DE19938621A1 (de) * | 1999-08-14 | 2001-02-22 | Sueddeutsche Kalkstickstoff | Verfahren zur Herstellung von lösemittelfreier alpha-Liponsäure |
IT1319195B1 (it) * | 2000-10-10 | 2003-09-26 | Laboratorio Chimico Int Spa | Processo per la produzione dell'acido r(+)alfa-lipoico. |
-
2000
- 2000-10-10 IT IT2000MI002188A patent/IT1319196B1/it active
-
2001
- 2001-10-08 AU AU2002220596A patent/AU2002220596A1/en not_active Abandoned
- 2001-10-08 JP JP2002534305A patent/JP4257574B2/ja not_active Expired - Fee Related
- 2001-10-08 ES ES01986686T patent/ES2219577T3/es not_active Expired - Lifetime
- 2001-10-08 DE DE60103179T patent/DE60103179T2/de not_active Expired - Lifetime
- 2001-10-08 EP EP01986686A patent/EP1335911B1/en not_active Expired - Lifetime
- 2001-10-08 WO PCT/EP2001/011576 patent/WO2002030919A1/en active IP Right Grant
- 2001-10-08 KR KR1020037004734A patent/KR100822532B1/ko not_active Expired - Fee Related
- 2001-10-08 AT AT01986686T patent/ATE266020T1/de not_active IP Right Cessation
- 2001-10-08 US US10/398,890 patent/US6864374B2/en not_active Expired - Lifetime
- 2001-10-08 CZ CZ20031007A patent/CZ301710B6/cs not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5281722A (en) * | 1991-11-16 | 1994-01-25 | Degussa Ag | Preparation and use of salts of the pure enantiomers of alpha-lipoic acid |
Also Published As
Publication number | Publication date |
---|---|
EP1335911A1 (en) | 2003-08-20 |
ES2219577T3 (es) | 2004-12-01 |
DE60103179T2 (de) | 2005-05-04 |
IT1319196B1 (it) | 2003-09-26 |
JP4257574B2 (ja) | 2009-04-22 |
KR20030070001A (ko) | 2003-08-27 |
ITMI20002188A1 (it) | 2002-04-10 |
AU2002220596A1 (en) | 2002-04-22 |
EP1335911B1 (en) | 2004-05-06 |
US20040002610A1 (en) | 2004-01-01 |
CZ301710B6 (cs) | 2010-06-02 |
WO2002030919A1 (en) | 2002-04-18 |
ITMI20002188A0 (it) | 2000-10-10 |
ATE266020T1 (de) | 2004-05-15 |
US6864374B2 (en) | 2005-03-08 |
DE60103179D1 (en) | 2004-06-09 |
JP2004511477A (ja) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3255996B2 (ja) | α−リポ酸の純粋な鏡像体の塩、その製造およびその単離方法 | |
KR100822532B1 (ko) | 알플러스알파-리포산의 합성 방법 | |
KR100822533B1 (ko) | 라세미 티옥트산의 제조 방법 | |
KR100838922B1 (ko) | 알플러스알파-리포산의 제조 방법 | |
CA2536667C (en) | Process for the preparation of z-flupentixol | |
US5900492A (en) | Method of producing optically active cyclopropane derivatives | |
US5591859A (en) | Process for the production of 2-cyanoiminothiazolidine | |
EP0437566B1 (en) | Phenyl-glycine derivatives | |
US5008409A (en) | Process for preparing 1,4-bridged cyclohexane carboxylic acid derivatives | |
WO1990008126A1 (en) | Resolution process | |
RU2175965C2 (ru) | 8-галоген-6-гидроксиоктановые кислоты, их эфиры, соли и способы их получения | |
IE66490B1 (en) | Process for racemate resolution of 2,2-dimethylcyclopropanecarboxylic acid | |
JP2001064275A (ja) | イソクマリン誘導体の光学分割方法 | |
JPS5896042A (ja) | α−ケト酸の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20030402 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20060920 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070831 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20080225 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20080408 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20080408 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20110323 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20120328 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130319 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20130319 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140326 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20140326 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160318 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20160318 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170317 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20170317 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180328 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20180328 Start annual number: 11 End annual number: 11 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20200119 |